Back
Aquestive Therapeutics Vs. Dave Industry Stock Comparison
Sell
25
AQST
Aquestive Therapeutics
Last Price:
$2.95
Seasonality Move:
9.3%
Buy
67
DAVE
Dave
Last Price:
$86.07
Seasonality Move:
-3.93%
Sell
25
Aquestive Therapeutics (AQST)
is a Sell
Is Aquestive Therapeutics a Buy, Sell or Hold?
-
The current Aquestive Therapeutics [AQST] share price is $2.64. The Score for AQST is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
AQST is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AQST Stock Price Chart
What is Aquestive Therapeutics's stock price today?
-
The Aquestive Therapeutics share price today is $2.64The current trend is relatively stagnant and AQST is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAVE Stock Price Chart
AQST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 40.08 | Sell |
Chaikin Money Flow: | 777220 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.71 - 3.17) | Sell |
Bollinger Bands (100): | (2.97 - 4.83) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.4 | Sell |
Relative Strength Index (14 RSI): | 35.37 | Sell |
Chaikin Money Flow: | -191798 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.86 - 110.32) | Sell |
Bollinger Bands (100): | (59.34 - 103.9) | Buy |
AQST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.7 | Sell |
20-day SMA: | 2.92 | Sell |
50-day SMA: | 3.11 | Sell |
200-day SMA: | 3.78 | Sell |
8-day EMA: | 2.71 | Sell |
20-day EMA: | 2.86 | Sell |
50-day EMA: | 3.18 | Sell |
200-day EMA: | 3.61 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.36 | Sell |
20-day SMA: | 100.85 | Sell |
50-day SMA: | 95.49 | Sell |
200-day SMA: | 59.5 | Buy |
8-day EMA: | 89.51 | Sell |
20-day EMA: | 95.46 | Sell |
50-day EMA: | 93.47 | Sell |
200-day EMA: | 66.68 | Buy |
Aquestive Therapeutics Earnings Growth & AQST Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.07 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.83 per share, an increase next quarter of $0.09 per share, an increase this year of $1.90 per share, and an increase next year of $0.79 per share.
Aquestive Therapeutics Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |